X0508 4 2024-11-02 false 0001645113 NovoCure Ltd NVCR 0002039078 Paravasthu Mukund C/O NOVOCURE INC. 1550 LIBERTY RIDGE DRIVE, SUITE 115 WAYNE PA 19087 false true false false Chief Operating Officer false Ordinary Shares 2024-11-02 4 S false 44.00 16.6858 D 3459.00 D Ordinary Shares 2024-11-04 4 A false 30138.00 0.00 A 33597.00 D Stock Option (Right to Buy) 16.59 2024-11-04 4 A false 45620.00 16.59 A 2034-11-03 Ordinary Shares 45620.00 45620.00 D Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Represents restricted share units that are scheduled to vest in equal parts on November 4, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates. Options to buy 45,620 ordinary shares will vest in equal installments on each of November 4, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates. Ovie Onobrakpeya, as attorney in fact for Paravasthu, Mukund 2024-11-06